- Home
- SQM vs ROIV Comparison
SQM vs ROIV Comparison
Compare SQM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQM | ROIV |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | Chile | United Kingdom |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0B | 21.0B |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SQM | ROIV |
|---|---|---|
| Price | $80.33 | $30.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $68.80 | $28.94 |
| AVG Volume (30 Days) | 1.0M | ★ 5.5M |
| Earning Date | 05-26-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.83 | $744.61 |
| P/E Ratio | $39.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.36 | $10.71 |
| 52 Week High | $98.00 | $32.79 |
Technical Indicators
Market Signals| Indicator | SQM | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 56.00 |
| Support Level | $68.06 | $26.65 |
| Resistance Level | $81.67 | N/A |
| Average True Range (ATR) | 3.32 | 1.12 |
| MACD | -1.74 | 0.20 |
| Stochastic Oscillator | 6.16 | 48.05 |
Price Performance
Historical ComparisonAbout SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.